Volume | 715,419 |
|
|||||
News | - | ||||||
Day High | 310.41 | Low High |
|||||
Day Low | 300.25 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
ICON PLC | ICLR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
302.85 | 300.25 | 310.41 | 308.31 | 300.08 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
19,967 | 715,419 | US$ 307.32 | US$ 219,865,329 | - | 181.92 - 344.77 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:20:01 | 9 | US$ 308.31 | USD |
ICON (ICLR) Options Flow Summary
ICON PLC Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
25.45B | 82.50M | - | 8.12B | 612.34M | 7.42 | 41.56 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
ICON News
Date | Time | Source | News Article |
---|---|---|---|
4/24/2024 | 15:15 | Business Wire | ICON Reports First Quarter 2024 Results |
4/03/2024 | 15:15 | Business Wire | ICON Announces CFO Transition |
3/25/2024 | 15:15 | Business Wire | ICON plc Schedules First Quarter 2024 Earnings Conference.. |
3/08/2024 | 15:37 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/06/2024 | 17:10 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/04/2024 | 17:38 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/04/2024 | 17:32 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/04/2024 | 17:25 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/04/2024 | 17:16 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
3/04/2024 | 17:05 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities |
2/26/2024 | 15:31 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2/26/2024 | 15:15 | Business Wire | ICON plc to Present at Upcoming Investor Conferences |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ICLR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 291.85 | 313.89 | 287.02 | 301.24 | 881,337 | 16.46 | 5.64% |
1 Month | 337.00 | 338.98 | 287.02 | 306.53 | 543,629 | -28.69 | -8.51% |
3 Months | 259.78 | 344.77 | 256.96 | 309.81 | 555,761 | 48.53 | 18.68% |
6 Months | 237.60 | 344.77 | 228.051 | 286.16 | 535,804 | 70.71 | 29.76% |
1 Year | 201.42 | 344.77 | 181.92 | 256.29 | 603,688 | 106.89 | 53.07% |
3 Years | 218.35 | 344.77 | 171.43 | 238.03 | 590,379 | 89.96 | 41.20% |
5 Years | 137.54 | 344.77 | 104.275 | 220.93 | 470,877 | 170.77 | 124.16% |
ICON Description
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland. |